In our study, kinases associated with the cell cycle (e.g., CDK2, CDK6) and the DNA damage response (e.g., ATM, ATR, CHEK2) were activated frequently in cancer, which is consistent with our previous research23. This evidence concerns the gene CHEK2 and cancer.